Perez, E A <br/><br/>
A risk-benefit assessment of serotonin 5-HT3 receptor antagonists in antineoplastic therapy-induced emesis.  [electronic resource] 

 -  Drug safety  Jan 1998 
 - 43-56 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0114-5916 
<br/><br/><label>Standard No.: </label>10.2165/00002018-199818010-00004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiemetics--economics<br/>Antineoplastic Agents--adverse effects<br/>Cost of Illness<br/>Humans<br/>Risk Assessment<br/>Serotonin Antagonists--economics<br/>Vomiting--chemically induced